BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 10, Issue 21
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (3147)
All Articles published online
The chart showing PDF series, HTML series, Tables (1-4) series.
Item 
Count 
PDF350
HTML2671
Tables (1-4)118
 Sum=3139
Nov 1, 2004 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Li XM, Shi MF, Yang YB, Shi ZJ, Hou HY, Shen HM, Teng BQ. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004; 10(21): 3215-3217 [PMID: 15457579 DOI: 10.3748/wjg.v10.i21.3215]
URL: https://www.wjgnet.com/1007-9327/full/v10/i21/3215.htm
Number Citing Articles
1
Mengyu Zhao, Huaibin Zou, Yu Chen, Sujun Zheng, Zhongping Duan. Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother‐to‐child transmission of hepatitis B virus. Journal of Viral Hepatitis 2019; 26(9): 1059 doi: 10.1111/jvh.13123
2
Zhao Zhang, Chao Chen, Zhe Li, Ying-Hua Wu, Xiao-Min Xiao. Individualized management of pregnant women with high hepatitis B virus DNA levels. World Journal of Gastroenterology 2014; 20(34): 12056-12061 doi: 10.3748/wjg.v20.i34.12056
3
M. M. YU, X. J GU, Y. XIA, G. J. WANG, N. Y. KAN, H. X. JIANG, K. H. WU, Y. JI, L. L. JU. Relationship between HBV cccDNA expression in the human ovary and vertical transmission of HBV. Epidemiology and Infection 2012; 140(8): 1454 doi: 10.1017/S0950268811002068
4
Zhe Chen, Min Zeng, Dan Liu, Lin Wu, Lingli Zhang. Antenatal administration of hepatitis B immunoglobulin and hepatitis B vaccine to prevent mother to child transmission in hepatitis B virus surface antigen positive pregnant women. Medicine 2020; 99(16): e19886 doi: 10.1097/MD.0000000000019886
5
Teerha Piratvisuth. Optimal management of HBV infection during pregnancy. Liver International 2013; 33(s1): 188 doi: 10.1111/liv.12060
6
Kazuto Tajiri, Yukihiro Shimizu. Unsolved problems and future perspectives of hepatitis B virus vaccination. World Journal of Gastroenterology 2015; 21(23): 7074-7083 doi: 10.3748/wjg.v21.i23.7074
7
Robert S. Brown, Brian J. McMahon, Anna S.F. Lok, John B. Wong, Ahmed T. Ahmed, Mohamed A. Mouchli, Zhen Wang, Larry J. Prokop, Mohammad Hassan Murad, Khaled Mohammed. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis. Hepatology 2016; 63(1): 319 doi: 10.1002/hep.28302
8
Genetic variant in CXCL13 gene is associated with susceptibility to intrauterine infection of hepatitis B virus. Scientific Reports 2016; 6(1) doi: 10.1038/srep26465
9
Minmin Yu, Qian Jiang, Xiaojun Gu, Lili Ju, Ying Ji, Kaihua Wu, Hongxiu Jiang, Man-Fung Yuen. Correlation between Vertical Transmission of Hepatitis B Virus and the Expression of HBsAg in Ovarian Follicles and Placenta. PLoS ONE 2013; 8(1): e54246 doi: 10.1371/journal.pone.0054246
10
Lin Ma, Nageswara R. Alla, Xiaomao Li, Ospan A. Mynbaev, Zhongjie Shi. Mother-to-child transmission of HBV: review of current clinical management and prevention strategies. Reviews in Medical Virology 2014; 24(6): 396 doi: 10.1002/rmv.1801
11
Catherine Williamson, Melanie Nana, Liona Poon, Limas Kupcinskas, Rebecca Painter, Gloria Taliani, Michael Heneghan, Hanns-Ulrich Marschall, Ulrich Beuers. EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy. Journal of Hepatology 2023; 79(3): 768 doi: 10.1016/j.jhep.2023.03.006
12
Jing Wang, Jinfeng Liu, Caijing Qi, Taotao Yan, Furong Cao, Li Jin, Yingli He, Yuan Yang, Shulin Zhang, Tianyan Chen, Yingren Zhao. Efficacy of Tenofovir Disoproxil Fumarate to Prevent Vertical Transmission in Mothers with Lamivudine-Resistant HBV. Antiviral Therapy 2015; 20(7): 681 doi: 10.3851/IMP2981
13
Robert S. Brown, Elizabeth C. Verna, Marcus R. Pereira, Hugh H. Tilson, Christopher Aguilar, Cheng-Shiun Leu, Maria Buti, Elizabeth A. Fagan. Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: Findings from the Antiretroviral Pregnancy Registry. Journal of Hepatology 2012; 57(5): 953 doi: 10.1016/j.jhep.2012.06.031
14
Xiaohong Shi, Xuefei Wang, Xixi Xu, Yongliang Feng, Shuzhen Li, Shuying Feng, Bo Wang, Suping Wang. Impact of HBV replication in peripheral blood mononuclear cell on HBV intrauterine transmission. Frontiers of Medicine 2017; 11(4): 548 doi: 10.1007/s11684-017-0597-5
15
M. Yu, Q. Jiang, Y. Ji, H. Jiang, K. Wu, L. Ju, X. Tang, M. Wu. The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus. European Journal of Clinical Microbiology & Infectious Diseases 2012; 31(9): 2211 doi: 10.1007/s10096-012-1557-2
16
Qingliang Shao, Xiaxia Zhao, M. D. Yao Li. Role of peripheral blood mononuclear cell transportation from mother to baby in HBV intrauterine infection. Archives of Gynecology and Obstetrics 2013; 288(6): 1257 doi: 10.1007/s00404-013-2893-x
17
J. Yuan, J. Lin, A. Xu, H. Li, B. Hu, J. Chen, J. Yao, H. Dong, M. Jiang. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single‐centre randomized study. Journal of Viral Hepatitis 2006; 13(9): 597 doi: 10.1111/j.1365-2893.2006.00738.x
18
Janet I. Andrews. High Risk Pregnancy. 2011; : 469 doi: 10.1016/B978-1-4160-5908-0.00027-2
19
Ussanee S Sangkomkamhang, Pisake Lumbiganon, Malinee Laopaiboon, Ussanee S Sangkomkamhang. Cochrane Database of Systematic Reviews. 2011;  doi: 10.1002/14651858.CD007879.pub2
20
Feifan Xiao, Aihua Lan, Wentao Mo. Breastfeeding from mothers carrying HBV would not increase the risk of HBV infection in infants after proper immunoprophylaxis. Minerva Pediatrica 2020; 72(2) doi: 10.23736/S0026-4946.17.04798-3
21
Beom Kyung Kim, Peter A Revill, Sang Hoon Ahn. HBV Genotypes: Relevance to Natural History, Pathogenesis and Treatment of Chronic Hepatitis B. Antiviral Therapy 2011; 16(8): 1169 doi: 10.3851/IMP1982
22
Anna Kramvis. The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics. Reviews in Medical Virology 2016; 26(4): 285 doi: 10.1002/rmv.1885
23
Min-Hui Liu, Yun-Jian Sheng, Jun-Ying Liu, Huai-Dong Hu, Qiong-Fang Zhang, Hong Ren. Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysis. Annals of Saudi Medicine 2013; 33(2): 169 doi: 10.5144/0256-4947.2013.169
24
Maya Gambarin-Gelwan. Hepatitis B in Pregnancy. Clinics in Liver Disease 2007; 11(4): 945 doi: 10.1016/j.cld.2007.08.004
25
Xiao Min Xiao, Ai Zhen Li, Xin Chen, Yao Kui Zhu, Jin Miao. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. International Journal of Gynecology & Obstetrics 2007; 96(3): 167 doi: 10.1016/j.ijgo.2006.11.011
26
Ahizechukwu C Eke, George U Eleje, Uzoamaka A Eke, Yun Xia, Jiao Liu. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus. Cochrane Database of Systematic Reviews 2017; 2017(2) doi: 10.1002/14651858.CD008545.pub2
27
Xiao-Hong Shi, Bo Wang, Shu-Ying Feng, Zhen Guo, Jian Guo, Xue-Fei Wang, Shu-Zhen Li, Yong-Liang Feng, Su-Ping Wang. Influential Factors of Hepatitis B Virus cccDNA in Peripheral Blood Mononuclear Cells Among HBsAg-Positive Pregnant Females Neonates. Hepatitis Monthly 2018; (In Press) doi: 10.5812/hepatmon.55064
28
CHIEN-YI CHEN, MEI-HWEI CHANG. HEPATITIS B AND PREGNANCY, THE SCIENTIFIC BASIS FOR PERINATAL PREVENTION. Fetal and Maternal Medicine Review 2010; 21(2): 89 doi: 10.1017/S0965539510000021
29
Silvia Degli Esposti, Dhvani Shah. Hepatitis B in Pregnancy: Challenges and Treatment. Gastroenterology Clinics of North America 2011; 40(2): 355 doi: 10.1016/j.gtc.2011.03.005
30
Jennifer S.M. Mak, Maran B.W. Leung, Cathy H.S. Chung, Jacqueline P.W. Chung, L.P. Cheung, Terence T Lao, T.C. Li. Presence of Hepatitis B virus DNA in follicular fluid in female Hepatitis B carriers and outcome of IVF/ICSI treatment: A prospective observational study. European Journal of Obstetrics & Gynecology and Reproductive Biology 2019; 239: 11 doi: 10.1016/j.ejogrb.2019.05.029
31
Elke Wiseman, Melissa A Fraser, Sally Holden, Anne Glass, Bronwynne L Kidson, Leon G Heron, Michael W Maley, Anna Ayres, Stephen A Locarnini, Miriam T Levy. Perinatal transmission of hepatitis B virus: an Australian experience. Medical Journal of Australia 2009; 190(9): 489 doi: 10.5694/j.1326-5377.2009.tb02524.x
32
J. GUO, Y. GAO, Z. GUO, L. R. ZHANG, B. WANG, S. P. WANG. Frequencies of dendritic cells and Toll-like receptor 3 in neonates born to HBsAg-positive mothers with different HBV serological profiles. Epidemiology and Infection 2015; 143(1): 62 doi: 10.1017/S0950268814000624
33
Premashis Kar, Anando Sengupta. Synthetic therapeutics for the treatment of hepatitis B during pregnancy. Expert Opinion on Pharmacotherapy 2018; 19(16): 1771 doi: 10.1080/14656566.2018.1527313
34
Michelle L. Giles, Kumar Visvanathan, Sharon R. Lewin, Joe Sasadeusz. Chronic Hepatitis B Infection and Pregnancy. Obstetrical & Gynecological Survey 2012; 67(1): 37 doi: 10.1097/OGX.0b013e31823e464b
35
Z. Guo, X. H. Shi, Y. L. Feng, B. Wang, L .P. Feng, S. P. Wang, Y. W. Zhang. Risk factors of HBV intrauterine transmission among HBsAg‐positive pregnant women. Journal of Viral Hepatitis 2013; 20(5): 317 doi: 10.1111/jvh.12032
36
J. Liu, T. Chen, Y. Zhao. Telbivudine therapy for gravidas with chronic hepatitis B infection and patients at risk of renal impairment. Journal of Viral Hepatitis 2017; 24(S1): 6 doi: 10.1111/jvh.12787
37
G. Benoist, I. Ollivier, B. Viaris de Lesegno, S. Gouarin, M. Herlicoviez. Le diagnostic prénatal en pratique. 2011; : 361 doi: 10.1016/B978-2-294-70962-3.00035-5
38
Qin Xu, Lin Xiao, Xiao-Bo Lu, Yue-Xin Zhang, Xia Cai. A randomized controlled clinical trial: Interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World Journal of Gastroenterology 2006; 12(21): 3434-3437 doi: 10.3748/wjg.v12.i21.3434
39
Yuzhu Yin, Lingling Wu, Jun Zhang, Jin Zhou, Peizhen Zhang, Hongying Hou. Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus. Journal of Infection 2013; 66(5): 447 doi: 10.1016/j.jinf.2012.12.008
40
Lei Zhang, Xi-en Gui, Caroline Teter, Hairong Zhong, Zhiyong Pang, Lixiong Ding, Fengliang Li, Yun Zhou, Ling Zhang. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine. Vaccine 2014; 32(46): 6091 doi: 10.1016/j.vaccine.2014.08.078
41
Luis Guillermo Toro-Rendón. Infección por el virus de la Hepatitis B en el embarazo. Revista Médicas UIS 2018; 31(2): 49 doi: 10.18273/revmed.v31n2-2018006
42
Biplab Bose, Navin Khanna, Subrat K. Acharya, Subrata Sinha. Generation and characterization of a high‐affinity chimaeric antibody against hepatitis B surface antigen. Biotechnology and Applied Biochemistry 2006; 43(2): 93 doi: 10.1042/BA20050187
43
Li-fen Han, Jian-ming Zheng, Li-qing Zheng, Hai-bing Gao, Li-xia Chen, Qing-ling Xu, Yi-hong Chai, Xin Zhang, Chen Pan, Lv-feng Yao. Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4250-6
44
Hui Jin, Yueyuan Zhao, Zhaoying Tan, Xuefeng Zhang, Yaoyun Zhao, Bei Wang, Pei Liu. Immunization interventions to interrupt hepatitis B virus mother-to-child transmission: a meta-analysis of randomized controlled trials. BMC Pediatrics 2014; 14(1) doi: 10.1186/s12887-014-0307-2
45
Jodie Dionne-Odom, Alan T.N. Tita, Neil S. Silverman. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. American Journal of Obstetrics and Gynecology 2016; 214(1): 6 doi: 10.1016/j.ajog.2015.09.100
46
Calvin Q. Pan, Zhong–Ping Duan, Kalyan R. Bhamidimarri, Huai–Bin Zou, Xiao–Feng Liang, Jie Li, Myron J. Tong. An Algorithm for Risk Assessment and Intervention of Mother to Child Transmission of Hepatitis B Virus. Clinical Gastroenterology and Hepatology 2012; 10(5): 452 doi: 10.1016/j.cgh.2011.10.041
47
Zhongjie Shi, Xiaomao Li, Lin Ma, Yuebo Yang. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission—a meta-analysis. International Journal of Infectious Diseases 2010; 14(7): e622 doi: 10.1016/j.ijid.2009.09.008
48
Maureen M. Jonas. Hepatitis B and pregnancy: an underestimated issue. Liver International 2009; 29(s1): 133 doi: 10.1111/j.1478-3231.2008.01933.x
49
Long H. Nguyen, Mindie H. Nguyen. Prevention of Mother-to-Child Transmission of Hepatitis B Virus: Is Elective Cesarean Section in Highly Viremic Mothers an Appropriate Adjunct to Immunoprophylaxis?. Clinical Gastroenterology and Hepatology 2013; 11(10): 1356 doi: 10.1016/j.cgh.2013.04.017
50
Y. GAO, J. GUO, F. ZHANG, Z. GUO, L.-R. ZHANG, T. WANG, B. WANG, S.-Y FENG, S.-P. WANG. Evaluation of neonatal Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in HBV intrauterine transmission susceptibility. Epidemiology and Infection 2015; 143(9): 1868 doi: 10.1017/S0950268814002921
51
Tram T. Tran, Stuart C. Gordon, Scott Fung, Phillip Dinh, Leland Yee, Eduardo Bruno Martins, Maria Buti, Patrick Marcellin, Claire Thorne. Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials. PLOS ONE 2015; 10(3): e0121632 doi: 10.1371/journal.pone.0121632
52
Xiaohui Zhang, Huaibin Zou, Yu Chen, Hua Zhang, Ruihua Tian, Jun Meng, Yunxia Zhu, Huimin Guo, Erhei Dai, Baoshen Zhu, Zhongsheng Liu, Yanxia Jin, Yujie Li, Liping Feng, Hui Zhuang, Calvin Q. Pan, Jie Li, Zhongping Duan. The effects of increased dose of hepatitis B vaccine on mother-to-child transmission and immune response for infants born to mothers with chronic hepatitis B infection: a prospective, multicenter, large-sample cohort study. BMC Medicine 2021; 19(1) doi: 10.1186/s12916-021-02025-1
53
Ussanee S Sangkomkamhang, Pisake Lumbiganon, Malinee Laopaiboon. Hepatitis B vaccination during pregnancy for preventing infant infection. Cochrane Database of Systematic Reviews 2014; 2014(11) doi: 10.1002/14651858.CD007879.pub3
54
Kui-Xia Sun, Jie Li, Feng-Cai Zhu, Jian-Xun Liu, Rong-Cheng Li, Xiang-Jun Zhai, Yan-Ping Li, Zhan-Jun Chang, Jing-Jing Nie, Hui Zhuang. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women. Vaccine 2012; 30(36): 5335 doi: 10.1016/j.vaccine.2012.06.036
55
Zhong‐Jun Shao, De‐Zhong Xu, Jian‐Qiu Xu, Jing‐Hua Li, Yong‐Ping Yan, Ke Men, Xue‐Ping Wang, Zhi‐Ying Zhang, Qin‐Wu Jiang, Lei Zhang. Maternal hepatitis B virus (HBV) DNA positivity and sexual intercourse are associated with HBV intrauterine transmission in China: A prospective case–control study. Journal of Gastroenterology and Hepatology 2007; 22(2): 165 doi: 10.1111/j.1440-1746.2006.04462.x
56
Piero Veronese, Icilio Dodi, Susanna Esposito, Giuseppe Indolfi. Prevention of vertical transmission of hepatitis B virus infection. World Journal of Gastroenterology 2021; 27(26): 4182-4193 doi: 10.3748/wjg.v27.i26.4182
57
Zhongjie Shi, Yuebo Yang, Lin Ma, Xiaomao Li, Ann Schreiber. Lamivudine in Late Pregnancy to Interrupt In Utero Transmission of Hepatitis B Virus. Obstetrics & Gynecology 2010; 116(1): 147 doi: 10.1097/AOG.0b013e3181e45951
58
Helene Bernstein. Obstetrics: Normal and Problem Pregnancies. 2007; : 1203 doi: 10.1016/B978-0-443-06930-7.50050-5
59
Zhao Zhang, Aizhen Li, Xiaomin Xiao. Risk factors for intrauterine infection with hepatitis B virus. International Journal of Gynecology & Obstetrics 2014; 125(2): 158 doi: 10.1016/j.ijgo.2013.10.028
60
Feng Ye, Yafei Yue, Shuhong Li, Tianyan Chen, Guiqin Bai, Min Liu, Shulin Zhang. Presence of HBsAg, HBcAg, and HBVDNA in ovary and ovum of the patients with chronic hepatitis B virus infection. American Journal of Obstetrics and Gynecology 2006; 194(2): 387 doi: 10.1016/j.ajog.2005.07.011
61
Purnima Bhat. Maternal Fetal Transmission of Human Viruses and their Influence on Tumorigenesis. 2012; : 195 doi: 10.1007/978-94-007-4216-1_6
62
Min Deng, Xin Zhou, Sheng Gao, Shi-Gui Yang, Bing Wang, Hua-Zhong Chen, Bing Ruan. The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis. Virology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-185
63
Konstantinos Tziomalos, Georgios Neokosmidis, Georgios Mavromatidis, Konstantinos Dinas. Novel insights in the prevention of perinatal transmission of hepatitis B. World Journal of Hepatology 2018; 10(11): 795-798 doi: 10.4254/wjh.v10.i11.795
64
Elizabeth Ramsey Unal, Gweneth B. Lazenby, Anne E. Lintzenich, Kit N. Simpson, Roger Newman, Laura Goetzl. Cost-Effectiveness of Maternal Treatment to Prevent Perinatal Hepatitis B Virus Transmission. Obstetrics & Gynecology 2011; 118(3): 655 doi: 10.1097/AOG.0b013e31822ad2c2
65
J.N. Zuckerman. Review: hepatitis B immune globulin for prevention of hepatitis B infection. Journal of Medical Virology 2007; 79(7): 919 doi: 10.1002/jmv.20816
66
Mei-Hwei Chang. Liver Disease in Children. 2014; : 276 doi: 10.1017/CBO9781139012102.019
67
Swati Sinha, Manoj Kumar. Pregnancy and chronic hepatitis B virus infection. Hepatology Research 2010; 40(1): 31 doi: 10.1111/j.1872-034X.2009.00597.x
68
Hua Xu, Teng Zeng, Jun-Ying Liu, Yu Lei, Shan Zhong, Yun-Jian Sheng, Zhi Zhou, Hong Ren. Measures to Reduce Mother-to-Child Transmission of Hepatitis B Virus in China: A Meta-Analysis. Digestive Diseases and Sciences 2014; 59(2): 242 doi: 10.1007/s10620-013-2918-0
69
Manoj Kumar, Tarandeep Singh, Swati Sinha. Chronic Hepatitis B Virus Infection and Pregnancy. Journal of Clinical and Experimental Hepatology 2012; 2(4): 366 doi: 10.1016/j.jceh.2012.09.001
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345